Published in J Am Stat Assoc on January 24, 2012
Covariate measurement error correction methods in mediation analysis with failure time data. Biometrics (2014) 2.10
Resampling Procedures for Making Inference under Nested Case-control Studies. J Am Stat Assoc (2013) 0.81
Robust risk prediction with biomarkers under two-phase stratified cohort design. Biometrics (2016) 0.75
Assessment of biomarkers for risk prediction with nested case-control studies. Clin Trials (2013) 0.75
Assessing incremental value of biomarkers with multi-phase nested case-control studies. Biometrics (2015) 0.75
IMPROVING EFFICIENCY IN BIOMARKER INCREMENTAL VALUE EVALUATION UNDER TWO-PHASE DESIGNS. Ann Appl Stat (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol (2004) 12.03
Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics (2000) 10.63
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
A nonidentifiability aspect of the problem of competing risks. Proc Natl Acad Sci U S A (1975) 7.37
Survival model predictive accuracy and ROC curves. Biometrics (2005) 7.26
The limitations of risk factors as prognostic tools. N Engl J Med (2006) 5.90
The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69
Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data. Biometrics (1975) 3.45
Median regression with censored cost data. Biometrics (2002) 3.34
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
A Z-theorem with Estimated Nuisance Parameters and Correction Note for 'Weighted Likelihood for Semiparametric Models and Two-phase Stratified Samples, with Application to Cox Regression' Scand Stat Theory Appl (2008) 2.26
Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome. J Am Stat Assoc (2008) 1.65
The sensitivity and specificity of markers for event times. Biostatistics (2005) 1.56
Design options for molecular epidemiology research within cohort studies. Cancer Epidemiol Biomarkers Prev (2005) 1.49
Survival model predictive accuracy and ROC curves. Biometrics (2005) 7.26
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59
The difference engine: a model of diversity in speeded cognition. Psychon Bull Rev (2003) 2.73
Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst (2002) 1.70
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res (2007) 1.61
The sensitivity and specificity of markers for event times. Biostatistics (2005) 1.56
Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease. Radiology (2002) 1.53
Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia? Am J Epidemiol (2013) 1.41
A unified mixed-effects model for rare-variant association in sequencing studies. Genet Epidemiol (2013) 1.29
Retracted DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res (2004) 1.26
Retracted Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. Int J Cancer (2006) 1.25
Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics (2011) 1.19
Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett (2006) 1.19
Evaluating the ROC performance of markers for future events. Lifetime Data Anal (2007) 1.16
Evaluating prognostic accuracy of biomarkers in nested case-control studies. Biostatistics (2011) 1.16
The association between worksite social support, diet, physical activity and body mass index. Prev Med (2011) 1.10
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. Clin Cancer Res (2008) 1.08
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. Int J Cancer (2009) 1.08
The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers. Clin Chem (2012) 1.05
Changes in cancer worry associated with participation in ovarian cancer screening. Psychooncology (2007) 1.04
Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women. Genes Chromosomes Cancer (2011) 0.99
Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer (2012) 0.97
Nidogen-2: a new serum biomarker for ovarian cancer. Clin Biochem (2009) 0.96
B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr (2012) 0.95
Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res (2004) 0.95
Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene (2005) 0.93
Determinants of aspirin metabolism in healthy men and women: effects of dietary inducers of UDP-glucuronosyltransferases. J Nutrigenet Nutrigenomics (2011) 0.93
Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr (2013) 0.92
The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res (2010) 0.91
Evaluating the predictive value of biomarkers with stratified case-cohort design. Biometrics (2012) 0.90
Vitamin D intake and lung cancer risk in the Women's Health Initiative. Am J Clin Nutr (2013) 0.89
The relationship between gravidity and parity and colorectal cancer risk. J Womens Health (Larchmt) (2009) 0.88
Robust prediction of t-year survival with data from multiple studies. Biometrics (2010) 0.87
Application of Multidimensional Selective Item Response Regression Model for Studying Multiple Gene Methylation in SV40 Oncogenic Pathways. J Am Stat Assoc (2008) 0.87
Model checking for ROC regression analysis. Biometrics (2007) 0.87
On combining triads and unrelated subjects data in candidate gene studies: an application to data on testicular cancer. Hum Hered (2008) 0.85
Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev (2010) 0.82
Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. Mol Oncol (2010) 0.82
Exploring the role of co-worker social support on health care utilization and sickness absence. J Occup Environ Med (2011) 0.80
Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women. J Nutr (2014) 0.80
Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. J Nutr (2014) 0.80
Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements. Horm Res (2008) 0.79
Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Int J Cancer (2014) 0.78
Promoting changes in obesogenic behaviors: does coworker social support play a role? Am J Health Promot (2014) 0.77
Assessment of biomarkers for risk prediction with nested case-control studies. Clin Trials (2013) 0.75
Subgroup specific incremental value of new markers for risk prediction. Lifetime Data Anal (2012) 0.75
Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore) (2017) 0.75
Assessing incremental value of biomarkers with multi-phase nested case-control studies. Biometrics (2015) 0.75
Retraction: DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res (2012) 0.75